Key Expert – Cancer Treatment Protocols Expert (Cat. II)
Project: Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.
Indicative
Start Date:
9 December 2026
Implementation Period: 14 months (indicative end date: 9 February 2028)
NTU International is currently identifying qualified experts for the EU-funded project “Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.”
The assignment aims to support the institutional strengthening and governance capacities of the Syrian Ministry of Health, contributing to more effective institutional performance, evidence-based decision-making, accountability and sustainable capacity development.
In this context, we are seeking a highly qualified Key Expert – Cancer Treatment Protocols Expert (Cat. II) to provide strategic and technical assistance in the development, harmonisation and implementation of evidence-based systemic anti-cancer therapy protocols, with particular emphasis on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance.
Qualifications and Skills Required- Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology-Oncology or Clinical Pharmacology
. - A Master's degree in Public Health or a related field is considered an asset
. - Strong capacity to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centres
. - Sound understanding of pharmaceutical supply-chain and quality-assurance considerations affecting essential cancer medicines.
- Ability to facilitate consensus-building among clinical stakeholders on standardised, evidence-based treatment pathways.
- Prior experience supporting ministries of health or national cancer-control programmes in post-conflict or early-recovery contexts is strongly preferred.
- Minimum 10 years of clinical or technical experience in medical oncology, including substantial direct experience in the development, harmonisation or revision of national or institutional systemic anti-cancer therapy protocols
, particularly chemotherapy protocols
.
- Demonstrated familiarity with current international treatment guidelines (e.g.
WHO Essential Medicines List for cancer
, NCCN
, ESMO
) and their contextual adaptation to resource-constrained or fragile health systems. - Proven experience developing or strengthening pharmacovigilance and medication-safety systems specific to chemotherapy administration
, including adverse-event reporting, dose-verification protocols and safe-handling procedures
. - Experience designing structured clinical training programmes for oncology teams (physicians, pharmacists and nursing staff) on protocol implementation,
treatment sequencing and toxicity management
. - Experience developing monitoring and evaluation tools to track treatment adherence
,clinical outcomes and protocol-related safety indicators across multiple oncology centres
.
- English: Excellent written and spoken command –
mandatory
. - Arabic: Working knowledge is considered a strong asset
.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).